期刊文献+

高同型半胱氨酸血症与脑梗死复发的关系 被引量:16

Relationship between hyperhomocysteinemia and the recurrence of cerebral infarction
下载PDF
导出
摘要 目的探讨高同型半胱氨酸血症(Hhcy)与脑梗死复发的关系。方法按血浆同型半胱氨酸(Hcy)水平,将139例急性脑梗死患者分为Hhcy组(42例,血Hcy≥15μmol/L)和非Hhcy(NHhcy)组(97例,血Hcy<15μmol/L)。给予入组者抗血小板治疗,以及控制已知的脑血管病危险因素等治疗;随访5年,观察两组脑梗死复发率及死亡率,分析影响脑梗死复发的危险因素。结果 Hhcy组脑梗死复发率(38.1%)和死亡率(19.0%)明显高于NHhcy组(15.5%,6.1%)(P<0.05~0.01)。Logistic回归分析显示,脑梗死复发与Hhcy(OR=1.110,95%CI:1.051~1.171,P<0.01)及糖尿病(OR=4.816,95%CI:1.693~13.697,P<0.01)有关。结论 Hhcy是脑梗死复发的独立危险因素之一。 Objective To explore the relationship between hyperhomocysteine(Hhcy) and the recurrence of cerebral infarction(CI).Methods According to the level of plasma homocysteine(Hcy),139 acute CI patients were divided into Hhcy group(42 cases,Hcy≥15 μmol/L) and non-Hhcy(NHhcy) group(97 cases,Hcy15 μmol/L).All of them received the treatment with antiplatelet and control risk factors of cerebrovascular disease.Then the recurrence rate of CI and the mortality of the 2 groups were observed by 5 years followed-up.The risk factors of CI recurrence were analyzed.Results The recurrence rate of CI and the mortality in Hhcy group(38.1%,19.0%) were significantly higher than that in NHhcy group(15.5%,6.1%)(P0.05-0.01).Logistic analysis showed that the recurrence of CI was related with Hhcy(OR=1.110,95%CI: 1.051-1.171,P0.01) and diabetes mellitus(OR=4.816,95%CI: 1.693-13.697,P0.01).Conclusion Hhcy is one of the independent risk factors of CI recurrence.
出处 《临床神经病学杂志》 CAS 北大核心 2012年第2期135-137,共3页 Journal of Clinical Neurology
关键词 脑梗死 复发 高同型半胱氨酸血症 cerebral infarction recurrence hyperhomocysteinemia
  • 相关文献

参考文献2

二级参考文献27

  • 1殷宪刚,吴宝川,张玉梅,邵建华.重组人生长激素对急性心肌梗死大鼠冠状动脉侧支循环的影响[J].临床心血管病杂志,2004,20(10):613-615. 被引量:4
  • 2李振英,朱惠萍,刘力,梁琳琳.同型半胱氨酸与脑血管病相关因素分析[J].临床神经病学杂志,2006,19(1):37-37. 被引量:19
  • 3李红伟,李焰生.同型半胱氨酸与神经系统疾病的研究进展[J].临床神经病学杂志,2006,19(6):474-475. 被引量:45
  • 4CHOY J C, GRANVILLE D J, HUNT D W, et al. Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis [J]. J Mol Cell Cardiol, 2001, 33 : 1673- 1690.
  • 5GERBER H P, McMURTREY A, KOWALSKI J, et al. Vascular endothelial growth factor regulates endothelial cell survival through the hosphatidylinositol 39- kinase/Akt signal transduction pathway[J].J Biol Chem, 1998, 273:30336-30343.
  • 6CLEAVER O, MELTON D A. Endothelial signaling during development[J].Nat Med, 2003,9 : 661-668.
  • 7GREENBERG D A, GIN K. From angiogenesis to neuropathology[J]. Nature, 2005, 438: 954-959.
  • 8YLA-HERTTUALA S, RISSANEN T T, VAJANTO I, et al. Vascular endothelial growth factors: Biology and current status of clinical application in cardiovascular medicine[J]. J Am Coll Cardiol, 2007, 49: 1015-1026.
  • 9WANG Y, ZHENG Y, ZHANG W, et al. Polymorphisms of KDR gene are associated with coronary heart disease[J].J Am Coll Cardiol, 2007, 50:760- 767.
  • 10ZHANG W L, WANG Y B, SUN K, et al. Vascular endothelial growth factor receptor 2 gene haplotype (TAT, -604/+1192/+1719) is associated with increased risk of hemorrhagic stroke: a multicenter case controlstudy[J].Circulation, 2006, 114: Ⅱ_490- 490.

共引文献29

同被引文献148

引证文献16

二级引证文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部